来曲唑卵巢刺激用于供精人工授精女性的回顾性分析
这项回顾性研究分析了2012至2015年间130个自然周期、939个来曲唑周期和130个来曲唑联合促性腺激素周期的供精人工授精临床妊娠率。来曲唑周期按HCG日LH浓度分组,妊娠率分别为17.3%、22.4%和26.8%(P=0.012)。在LH≥10 mIU/ml的女性中,雌二醇(OR 1.002,95%CI 1.000至1.004,P=0.029)和主导卵泡大小(OR 0.861,95%CI 0.772至0.960,P=0.007)是妊娠率的显著预测因素;来曲唑联合促性腺激素组妊娠率显著高于来曲唑组(P=0.04)。
要点
- 来曲唑周期按HCG日LH分组,妊娠率分别为17.3%、22.4%和26.8%(P=0.012)。
- LH≥10 mIU/ml时,雌二醇越高、卵泡越小,妊娠率越好。
- 来曲唑联合促性腺激素组妊娠率显著高于来曲唑组(P=0.04)。
核心结论
- 若LH峰在HCG给药前出现,尤其雌二醇较高和卵泡较小时,可获得更好的妊娠率。
- 来曲唑联合促性腺激素在供精人工授精中比单用来曲唑显著更有效。
研究设计与样本
- 回顾性研究,分析2012至2015年间130个自然周期、939个来曲唑周期和130个来曲唑联合促性腺激素周期。
- 来曲唑周期按HCG日LH浓度分为三组:LH<10 mIU/ml且卵泡大小≥18 cm、LH≤10至<20 mIU/ml、LH≥20 mIU/ml。
主要发现
- 三组妊娠率分别为17.3%、22.4%和26.8%(P=0.012)。
- 在LH≥10 mIU/ml的女性中, logistic回归显示雌二醇(OR 1.002,95%CI 1.000至1.004,P=0.029)和主导卵泡大小(OR 0.861,95%CI 0.772至0.960,P=0.007)是妊娠率的显著预测因素。
- 来曲唑联合促性腺激素组妊娠率显著高于来曲唑组(P=0.04)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The aim of this retrospective study was to determine the clinical pregnancy rate in women undergoing letrozole ovarian stimulation and artificial insemination by donor (AID). Between 2012 and 2015, 130 natural cycles, 939 letrozole cycles and 130 letrozole plus gonadotrophin cycles were conducted. Letrozole cycles were divided into three groups according to LH concentration on the day of HCG administration (LH <10 mIU/ml and follicle size ≥18 cm; LH ≤10 to <20 mIU/ml; and LH ≥20 mIU/ml). Pregnancy rates were 17.3%, 22.4% and 26.8%, respectively (P = 0.012). In women given 10 mIU/ml LH or more, logistic regression identified oestradiol (OR 1.002, 95% CI, 1.000 to 1.004, P = 0.029) and leading follicle size (OR 0.861, 95% CI, 0.772 to 0.960, P = 0.007) as significant predictive factors of pregnancy rate; the higher the oestradiol and the smaller the follicles, the better the pregnancy rate. The pregnancy rate was significantly higher in the letrozole plus gonadotrophin group than the letrozole group (P = 0.04). Better pregnancy rates can be achieved if LH surge occurs before HCG administration, especially with higher oestradiol and lower follicle size; treatment with letrozole plus gonadotrophin was significantly more effective than letrozole alone in AID.
引用
- Sun XJ, Jiang L, Ji LC, et al. A retrospective analysis of ovarian stimulation with letrozole in women undergoing artificial insemination by donor. Reprod Biomed Online. 2017. PMID: 28187961. doi:10.1016/j.rbmo.2017.01.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。